Skip to main content
Glenmark launches Covid-19 drug FabiFlu, priced at Rs 103 per tablet
Drug firm Glenmark Pharmaceuticals on
Saturday said it has launched antiviral drug Favipiravir, under the
brand name FabiFlu, for the treatment of patients with mild to moderate
Covid-19 at a price of about Rs 103 per tablet.
The drug will be available as a 200 mg tablet at a maximum retail price (MRP)of Rs 3,500 for a strip of 34 tablets, Glenmark Pharmaceuticals said.
FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19, it said in a statement.
Read more...
Comments
Post a Comment